AACR24: Pasi Janne, MD, PhD, Lung Cancer | Dana-Farber Cancer Institute [Video]

Lung Cancer data at AACR24: Dana-Farber’s Pasi Jänne, MD, PhD, reports on ctDNA with an EGFR mutation in FLAURA2 trial. The new data shows patients whose blood tested positive before therapy for tumor cell DNA with EGFR mutations stood to gain the most from combination therapy.
Video published 4/10/2024